Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
The FDA has launched a new initiative to accelerate the review process for new pharmaceutical manufacturing facilities.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The FDA has introduced a program designed to speed up the review of new manufacturing facilities to get medicines to market more quickly. Eli Lilly, Regeneron, and Kriya are among the first companies selected to participate in the initiative.
Coverage from CNBC, Reuters, Yahoo, and Business Wire emphasizes the selection of these specific companies for the pilot. The program is identified by Business Wire as the FDA PreCheck Pilot Program.
Future developments involve the implementation of this strategy to reduce timelines for facility reviews and the subsequent delivery of medications to the market.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 3h ago.
Quick answers
Which companies were selected for the FDA initiative?
Eli Lilly, Regeneron, and Kriya are among the companies selected.
What is the goal of this FDA program?
The strategy aims to review new manufacturing facilities faster to get medicines to the market more quickly.
What is the official name of the pilot program?
According to Business Wire, it is the FDA PreCheck Pilot Program.
Coverage (6)
- FDA PreCheck Could Speed Up These 3 U.S. Biopharma Stocks simplywall.st · 6h ago
- Kriya Selected for FDA PreCheck Pilot Program Business Wire · 6h ago
- Lilly, Regeneron selected for US program to review new manufacturing facilities faster, CNBC reports Yahoo · 6h ago
- Lilly, Regeneron selected for US program to review new manufacturing plants faster, CNBC reports Reuters · 6h ago
- A new FDA strategy aims to get medicines to the market faster Baton Rouge Business Report · 6h ago
- Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities CNBC · 6h ago broke it first
People, places & organizations
Topics
Related trends
Supplements sold online through major retailers recalled nationwide over potential salmonella risk
Major online retailers are recalling TNVitamins moringa powder supplements nationwide due to potential salmonella contamination.
Nearly 1 million bottles of heart and kidney medication recalled over foreign substance found on tablets
Nearly 1 million bottles of heart and kidney medications have been recalled nationwide due to the discovery of foreign substances on the tablets.
Potato chip recall upgraded to highest FDA risk level over salmonella concerns
The FDA has classified a massive recall of Utz potato chip brands as a Class I risk due to potential salmonella contamination.
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026
Eli Lilly shares surge following a CHMP recommendation for Jaypirca's EU approval to treat chronic lymphocytic leukemia.
New Drugs Are Replacing Chemo for Aggressive Breast Cancer
The FDA has granted broad first-line approval for Gilead's Trodelvy, signaling a shift away from traditional chemotherapy for aggressive breast cancer.
Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America
Eli Lilly's CEO outlines the transformative potential of GLP-1s as new oral weight-loss medications enter development.